Oncology 2025 Review: Curative-Intent Expansion, ADC Acceleration, and the Operationalization of Immunotherapy
The defining idea of 2025 was execution at scale—more patients pulled into…
SABCS 2025 Preview: Key Breast Cancer Highlights to Watch
Get ready for SABCS25 with LucidQuest’s concise preview of the sessions…
Lucid Diligence Brief: Abbott to acquire Exact Sciences
Lucid Diligence Brief: Abbott to acquire Exact Sciences Professional audiences…
Lucid Diligence Brief: Guardant Health and Zephyr AI partnership
Lucid Diligence Brief: Guardant Health and Zephyr AI partnership Professional…
Oncology Weekly News - August 25th 2025
🔬🧬 Oncology Updates: Iza-bren FDA Breakthrough, Inhaled KB707 Data, AI in…
Oncology Weekly News - July 14th 2025
🔬🧬 Oncology Updates: CAR-T Orphan Win, EU NPC Approval, Liver Cancer Combo OK…
ESMO GI 2025 Preview: Key Gastrointestinal Oncology Highlights to Watch
ESMO GI 2025 at a glance Get ready for ESMO GI 2025 with LucidQuest’s…
How our competitive simulation workshop helped a large pharma in precision oncology, develop its branding strategy for upcoming EU launches.
The Challenge: Formulating a brand strategy for new treatment launches in…